Aliases & Classifications for Myofibroma

MalaCards integrated aliases for Myofibroma:

Name: Myofibroma 12 43 15 17 71
Solitary Myofibromatosis 71
Uterine Fibroids 71
Lipoleiomyoma 12
Myolipoma 71

Classifications:



External Ids:

Disease Ontology 12 DOID:4386
MeSH 43 D047708
SNOMED-CT 67 128917003
UMLS 71 C0042133 C1096309 C1266121 more

Summaries for Myofibroma

MalaCards based summary : Myofibroma, also known as solitary myofibromatosis, is related to pleomorphic lipoma and leiomyoma, and has symptoms including pelvic pain An important gene associated with Myofibroma is RELA (RELA Proto-Oncogene, NF-KB Subunit), and among its related pathways/superpathways is Mesenchymal Stem Cells and Lineage-specific Markers. The drugs Leuprolide and Anastrozole have been mentioned in the context of this disorder. Affiliated tissues include uterus, breast and prostate, and related phenotypes are Reduced mammosphere formation and cellular

Related Diseases for Myofibroma

Diseases related to Myofibroma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 268, show less)
# Related Disease Score Top Affiliating Genes
1 pleomorphic lipoma 30.9 SERPINA3 CD34
2 leiomyoma 30.8 S100A1 DES CD34
3 myopericytoma 30.5 SRF RELA PDGFRB
4 epulis 30.4 SERPINA3 DES
5 infantile myofibromatosis 30.4 PDGFRB MIR143 MB ETV6 DES CD34
6 lipomatosis, multiple 30.3 SERPINA3 DES CD34 CALD1
7 neurofibroma 30.3 S100A1 F13A1 CD34
8 intravenous leiomyomatosis 30.1 DES CD34 CALD1
9 liposarcoma 30.0 MYOG MB DES CD34
10 glomus tumor 29.8 S100A1 DES CD34 CALD1
11 fibroma 29.6 SERPINA3 S100A1 F13A1 DES CD34
12 rhabdomyosarcoma 29.5 PDGFRB MYOG MB DES
13 horner's syndrome 29.4 MYOG DES
14 hemangiopericytoma, malignant 29.2 SERPINA3 MYOG F13A1 DES CD34 CALD1
15 well-differentiated liposarcoma 29.2 SERPINA3 MYOG CD34 CALD1
16 spindle cell sarcoma 29.1 SERPINA3 MYOG DES CD34
17 neurilemmoma 29.1 SERPINA3 S100A1 PDGFRB DES CD34
18 sarcoma, synovial 29.1 SERPINA3 MYOG DES CD34
19 pseudosarcomatous fibromatosis 29.0 SERPINA3 MYOG DES CD34 CALD1
20 connective tissue benign neoplasm 29.0 SERPINA3 PDGFRB CD34 CD1A CALD1
21 ewing sarcoma 28.9 PDGFRB MYOG DES CD34
22 smooth muscle tumor 28.9 SERPINA3 S100A1 MIR143 DES CD34 CALD1
23 congenital fibrosarcoma 28.8 SERPINA3 S100A1 MYOG ETV6 DES
24 mesenchymal cell neoplasm 28.8 SERPINA3 PDGFRB MYOG CD34 CALD1
25 fibrous histiocytoma 28.8 SERPINA3 MYOG F13A1 DES CD34
26 leiomyosarcoma 28.8 SERPINA3 S100A1 PDGFRB MYOG MB DES
27 sarcoma 28.6 SERPINA3 S100A1 PDGFRB MYOG DES
28 uterine corpus lipoleiomyoma 12.3
29 curry-jones syndrome 11.5
30 giant cell myocarditis 10.5 MB DES
31 fibroblastic rheumatism 10.5 F13A1 DES
32 ischemic fasciitis 10.5 S100A1 DES
33 alk+ histiocytosis 10.4 F13A1 CD1A
34 fibromatosis 10.4
35 exophthalmos 10.4
36 parachordoma 10.4 S100A1 DES
37 reticulum cell sarcoma 10.4 S100A1 DES
38 cutaneous leiomyosarcoma 10.4 DES CALD1
39 granuloma annulare 10.4 F13A1 CD1A
40 cellular leiomyoma 10.4 DES CALD1
41 ossifying fibromyxoid tumor 10.4 S100A1 DES
42 cystic teratoma 10.3
43 teratoma 10.3
44 congenital epulis 10.3 SERPINA3 DES
45 verruciform xanthoma of skin 10.3 SERPINA3 CD1A
46 erythema elevatum diutinum 10.3 F13A1 CD34
47 syringocystadenoma papilliferum 10.3 SERPINA3 DES
48 reticulohistiocytic granuloma 10.3 SERPINA3 CD1A
49 orbital cancer 10.3 CD34 CD1A
50 leiomyoma, uterine 10.3
51 mature teratoma 10.3
52 hemangioma 10.3
53 rare tumor 10.3
54 intravascular angioleiomyoma 10.3 CD34 CALD1
55 breast myofibroblastoma 10.3 CD34 CALD1
56 pulmonary vein leiomyosarcoma 10.3 CD34 CALD1
57 glomangiomyoma 10.3 CD34 CALD1
58 angiomyoma 10.3 CD34 CALD1
59 malignant giant cell tumor of soft parts 10.3 MB CD34
60 interdigitating dendritic cell sarcoma 10.3 SERPINA3 CD1A
61 deep leiomyoma 10.3 CD34 CALD1
62 nephrogenic adenofibroma 10.3 CD34 CALD1
63 glomangiosarcoma 10.3 CD34 CALD1
64 chondromyxoid fibroma 10.3 S100A1 DES
65 colon leiomyosarcoma 10.3 CD34 CALD1
66 multicentric reticulohistiocytosis 10.3 SERPINA3 F13A1
67 benign perivascular tumor 10.3 CD34 CALD1
68 cellular schwannoma 10.3 S100A1 CD34
69 carcinosarcoma 10.2 S100A1 MB DES
70 skin sarcoma 10.2 CD34 CALD1
71 small intestine leiomyoma 10.2 CD34 CALD1
72 histiocytic and dendritic cell cancer 10.2 SERPINA3 CD1A
73 fibrosarcoma 10.2
74 retroperitoneal leiomyosarcoma 10.2 CD34 CALD1
75 benign teratoma 10.2
76 angiomyolipoma 10.2
77 testicular fibroma 10.2 CD34 CALD1
78 chondroid chordoma 10.2 SERPINA3 S100A1
79 vulvar leiomyoma 10.2 CD34 CALD1
80 intravascular fasciitis 10.2 CD34 CALD1
81 congenital granular cell tumor 10.2 CD34 CALD1
82 central epithelioid sarcoma 10.2 MB CD34 CD1A
83 vulvar proximal-type epithelioid sarcoma 10.2 MB CD34 CD1A
84 congenital heart defects, hamartomas of tongue, and polysyndactyly 10.2
85 neurofibromatosis 10.2
86 fasciitis 10.2
87 myxosarcoma 10.2 S100A1 MB CALD1
88 lung sarcoma 10.2 SERPINA3 CD34
89 adenosarcoma 10.2 SERPINA3 MB DES
90 vaginal endometrial stromal sarcoma 10.2 CD34 CALD1
91 infiltrating angiolipoma 10.2 CD34 CALD1
92 uterine carcinosarcoma 10.2 S100A1 MB DES
93 esophagus sarcoma 10.2 CD34 CALD1
94 breast malignant phyllodes tumor 10.1 SERPINA3 CD34
95 subungual glomus tumor 10.1 CD34 CALD1
96 breast cancer 10.1
97 adenomyosis 10.1
98 fibrous meningioma 10.1 F13A1 CD34
99 spindle cell lipoma 10.1 DES CD34 CALD1
100 granular cell tumor 10.1 SERPINA3 S100A1 DES
101 gallbladder leiomyosarcoma 10.1 MB CD34 CALD1
102 breast leiomyosarcoma 10.1 MB CD34 CALD1
103 benign peritoneal mesothelioma 10.1 CD34 CALD1
104 glomangiomatosis 10.1 MB CD34 CALD1
105 conventional fibrosarcoma 10.1 MB CD34 CALD1
106 breast secretory carcinoma 10.1 SERPINA3 ETV6
107 malignant fibrous histiocytoma of bone 10.1 SERPINA3 DES CALD1
108 polyclonal hypergammaglobulinemia 10.1 SERPINA3 CD1A
109 primary hypereosinophilic syndrome 10.1 PDGFRB ETV6
110 frontal convexity meningioma 10.1 S100A1 PDGFRB
111 erdheim-chester disease 10.1 SERPINA3 CD1A
112 tenosynovial giant cell tumor 10.1 SERPINA3 CD34
113 breast rhabdomyosarcoma 10.1 MYOG MB
114 orbit rhabdomyosarcoma 10.1 MYOG MB
115 inflammatory leiomyosarcoma 10.1 MYOG DES
116 gallbladder sarcoma 10.1 MYOG DES
117 cystic lymphangioma 10.1 SERPINA3 CD34
118 malignant granular cell myoblastoma 10.1 SERPINA3 MB CD34
119 myeloproliferative disorder, chronic, with eosinophilia 10.0 PDGFRB ETV6
120 skeletal muscle neoplasm 10.0 MYOG MB
121 neurofibrosarcoma 10.0 S100A1 CD34
122 adult xanthogranuloma 10.0 SERPINA3 CD34 CD1A
123 orbit embryonal rhabdomyosarcoma 10.0 MYOG MB
124 myeloid and lymphoid neoplasms associated with pdgfra rearrangement 10.0 PDGFRB ETV6
125 fibrosarcoma of bone 10.0 SERPINA3 CD1A
126 malignant spindle cell melanoma 10.0 SERPINA3 CD34
127 desmoid tumor 10.0 PDGFRB DES CD34
128 teratoma, ovarian 10.0
129 ovarian cancer 10.0
130 schistosoma mansoni infection, susceptibility/ 10.0
131 endometrial cancer 10.0
132 gallbladder disease 10.0
133 endometrial hyperplasia 10.0
134 diarrhea 10.0
135 schistosomiasis 10.0
136 hypothyroidism 10.0
137 melanoma 10.0
138 constipation 10.0
139 endometriosis 10.0
140 teratocarcinoma 10.0
141 gastric adenocarcinoma 10.0
142 leukorrhea 10.0
143 ovarian germ cell teratoma 10.0
144 pleomorphic liposarcoma 10.0
145 kidney angiomyolipoma 10.0
146 ileus 10.0
147 hemometra 10.0
148 ring chromosome 10 10.0
149 uterine sarcoma 10.0
150 ring chromosome 10.0
151 ovarian fibroma 10.0
152 rare benign ovarian tumor 10.0
153 cavernous hemangioma 10.0 S100A1 MB DES CD34
154 skin tag 10.0 SERPINA3 CD34
155 lung combined type small cell carcinoma 10.0 MYOG CALD1
156 sarcomatoid squamous cell skin carcinoma 10.0 SERPINA3 CD34 CALD1
157 conventional leiomyosarcoma 10.0 MYOG CALD1
158 prostate embryonal rhabdomyosarcoma 10.0 MYOG CALD1
159 non-langerhans-cell histiocytosis 10.0 SERPINA3 F13A1 DES CD1A
160 cardiovascular organ benign neoplasm 10.0 SERPINA3 MIR143 CD34
161 lymphangioma 10.0 SERPINA3 MIR143 CD34
162 reproductive organ benign neoplasm 9.9 SERPINA3 CD34 CALD1
163 hirschsprung disease 1 9.9
164 nevus, epidermal 9.9
165 chondrosarcoma 9.9
166 myofibromatosis, infantile, 1 9.9
167 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 9.9
168 deficiency anemia 9.9
169 ptosis 9.9
170 suppression amblyopia 9.9
171 amblyopia 9.9
172 intestinal atresia 9.9
173 neonatal anemia 9.9
174 acoustic neuroma 9.9
175 lagophthalmos 9.9
176 scleritis 9.9
177 facial paralysis 9.9
178 neuroma 9.9
179 hyperostosis 9.9
180 myoepithelioma 9.9
181 complex regional pain syndrome 9.9
182 systemic scleroderma 9.9
183 mesenchymal chondrosarcoma 9.9
184 leiomyomatosis 9.9
185 paget's disease of bone 9.9
186 eye disease 9.9
187 cornea cancer 9.9
188 appendicitis 9.9
189 intestinal obstruction 9.9
190 localized scleroderma 9.9
191 polyhydramnios 9.9
192 orbital disease 9.9
193 keloid disorder 9.9
194 47,xyy 9.9
195 encephalocele 9.9
196 inflammatory linear verrucous epidermal nevus 9.9
197 odontogenic myxoma 9.9
198 pyogenic granuloma 9.9
199 paresthesia 9.9
200 posttransplant acute limbic encephalitis 9.9
201 congenital smooth muscle hamartoma 9.9
202 rare soft tissue tumor 9.9
203 retroperitoneum carcinoma 9.9 CD34 CALD1
204 liposarcoma of bone 9.9 MYOG CD34
205 angiolipoma 9.9 F13A1 DES CD34 CALD1
206 hobnail hemangioma 9.9 MYOG CD34
207 epithelioid leiomyosarcoma 9.9 SERPINA3 MB DES CALD1
208 malignant triton tumor 9.9 MYOG MB DES
209 medullomyoblastoma 9.9 MYOG MB DES
210 botryoid rhabdomyosarcoma 9.9 MYOG MB DES
211 prostate sarcoma 9.9 MYOG CD34
212 sarcomatous intrahepatic cholangiocarcinoma 9.9 PDGFRB CD34 CALD1
213 spindle cell rhabdomyosarcoma 9.9 MYOG MB DES
214 undifferentiated embryonal sarcoma of the liver 9.9 SERPINA3 MYOG
215 bilateral retinoblastoma 9.9 MYOG MB DES
216 heart sarcoma 9.9 MYOG CD34
217 glomangioma 9.9 S100A1 DES CD34 CALD1
218 bladder sarcoma 9.9 SERPINA3 MYOG
219 juvenile xanthogranuloma 9.9 SERPINA3 S100A1 F13A1 CD1A
220 embryonal rhabdomyosarcoma 9.9 MYOG MB DES
221 scrotum neoplasm 9.9 SERPINA3 MYOG
222 rhabdomyosarcoma 2 9.9 MYOG MB DES
223 ectomesenchymoma 9.9 S100A1 MYOG DES
224 epithelioid malignant peripheral nerve sheath tumor 9.8 MYOG CD34
225 breast sarcoma 9.8 MYOG CD34
226 uterus leiomyosarcoma 9.8 MYOG CALD1
227 endometrial stromal sarcoma 9.8 PDGFRB MB DES CALD1
228 adult malignant schwannoma 9.8 MYOG CD34
229 prostate stromal sarcoma 9.8 MYOG CD34
230 cell type benign neoplasm 9.8 SERPINA3 MIR143 CD34
231 embryonal sarcoma 9.8 SERPINA3 MYOG DES
232 sweat gland benign neoplasm 9.7 SERPINA3 CD34
233 gliosarcoma 9.7 SERPINA3 PDGFRB CD34
234 chordoma 9.7 SERPINA3 S100A1 PDGFRB DES
235 gastrointestinal stromal tumor 9.7 S100A1 PDGFRB DES CD34
236 gas gangrene 9.7 SERPINA3 MYOG MB
237 extraosseous osteosarcoma 9.7 MYOG CD34 CALD1
238 endobronchial leiomyoma 9.7 MYOG CD34 CALD1
239 retroperitoneal sarcoma 9.7 MYOG CD34 CALD1
240 kidney cortex disease 9.7 MYOG ETV6
241 vagina sarcoma 9.7 MYOG CD34 CALD1
242 muscle tissue disease 9.6 SERPINA3 MYOG MB
243 liver sarcoma 9.6 SERPINA3 MYOG CD34
244 heart cancer 9.6 SERPINA3 MYOG CD34
245 cutaneous fibrous histiocytoma 9.6 SERPINA3 S100A1 F13A1 DES CD34
246 synovium cancer 9.6 SERPINA3 MYOG CD34
247 x-linked recessive disease 9.5 SERPINA3 MYOG CD34
248 pediatric fibrosarcoma 9.5 SERPINA3 MYOG ETV6
249 neuromuscular disease 9.5 SERPINA3 MYOG MB DES
250 cervical polyp 9.5 MYOG DES CD34 CALD1
251 alveolar soft part sarcoma 9.5 PDGFRB MYOG MB DES
252 skeletal muscle cancer 9.4 SERPINA3 MYOG MB CD34
253 muscular disease 9.4 SERPINA3 MYOG MB CD34
254 mixed cell type cancer 9.3 SERPINA3 MYOG CD34 CALD1
255 cardiovascular cancer 9.3 SERPINA3 MYOG CD34 CALD1
256 malignant peripheral nerve sheath tumor 9.3 S100A1 PDGFRB MYOG CD34
257 adult fibrosarcoma 9.3 MYOG ETV6 CD34 CALD1
258 skin disease 9.3 SRF SERPINA3 F13A1 CD1A
259 leber plus disease 9.3 SERPINA3 MYOG CD34 CD1A
260 dermatofibrosarcoma protuberans 9.2 SERPINA3 S100A1 PDGFRB F13A1 DES CD34
261 myxofibrosarcoma 9.2 SERPINA3 MYOG DES CD34 CALD1
262 hematologic cancer 9.2 SERPINA3 PDGFRB MIR143 ETV6 CD34
263 malignant mesenchymoma 9.0 SERPINA3 MYOG MB DES CD34 CALD1
264 muscle cancer 9.0 SERPINA3 MYOG MB DES CD34 CALD1
265 malignant fibrous histiocytoma 9.0 SERPINA3 PDGFRB MYOG MB F13A1 DES
266 vascular cancer 9.0 SERPINA3 PDGFRB MYOG CD34 CALD1
267 inflammatory myofibroblastic tumor 8.9 MYOG F13A1 ETV6 DES CD34 CALD1
268 dedifferentiated liposarcoma 8.5 SERPINA3 S100A1 MYOG MB F13A1 DES

Comorbidity relations with Myofibroma via Phenotypic Disease Network (PDN): (showing 9, show less)


Asherman's Syndrome Cervix Uteri Carcinoma in Situ
Chronic Salpingo-Oophoritis Endometriosis
Endometriosis of Ovary Female Stress Incontinence
Hemometra Ovarian Cancer
Salpingo-Oophoritis

Graphical network of the top 20 diseases related to Myofibroma:



Diseases related to Myofibroma

Symptoms & Phenotypes for Myofibroma

UMLS symptoms related to Myofibroma:


pelvic pain

GenomeRNAi Phenotypes related to Myofibroma according to GeneCards Suite gene sharing:

26 (showing 1, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Reduced mammosphere formation GR00396-S 9.1 CD1A CD34 DES ETV6 F13A1 SRF

MGI Mouse Phenotypes related to Myofibroma:

45 (showing 3, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.81 CD34 DES ETV6 MB MYOG PDGFRB
2 homeostasis/metabolism MP:0005376 9.7 CD34 DES ETV6 F13A1 MB MYOG
3 muscle MP:0005369 9.17 DES MB MYOG PDGFRB RELA S100A1

Drugs & Therapeutics for Myofibroma

Drugs for Myofibroma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 228, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Leuprolide Approved, Investigational Phase 4 53714-56-0 657181 3911
2
Anastrozole Approved, Investigational Phase 4 120511-73-1 2187
3
Dienogest Approved Phase 4 65928-58-7
4
Desogestrel Approved Phase 4 54024-22-5 40973
5
Ferrous fumarate Approved Phase 4 141-01-5
6
Methylcobalamin Approved, Investigational Phase 4 13422-55-4
7
leucovorin Approved Phase 4 58-05-9 6006 143
8
Zinc Approved, Investigational Phase 4 7440-66-6 32051
9
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
10
Hydroxocobalamin Approved Phase 4 13422-51-0 15589840 11953898
11
Zinc oxide Approved Phase 4 1314-13-2
12
Tocopherol Approved, Investigational Phase 4 1406-66-2, 54-28-4 14986
13
Calcium carbonate Approved, Investigational Phase 4 471-34-1
14
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
15
Ibuprofen Approved Phase 4 15687-27-1 3672
16
Cetrorelix Approved, Investigational Phase 4 120287-85-6 16129715 25074887
17
Goserelin Approved Phase 4 65807-02-5 5311128 47725
18
Ketorolac Approved Phase 4 66635-83-4, 74103-06-3 3826
19
Acetaminophen Approved Phase 4 103-90-2 1983
20
Dinoprostone Approved Phase 4 363-24-6 5280360
21
Oxytocin Approved, Vet_approved Phase 4 50-56-6 53477758 439302
22
Morphine Approved, Investigational Phase 4 57-27-2 5288826
23
Clotrimazole Approved, Vet_approved Phase 4 23593-75-1 2812
24
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
25
Sirolimus Approved, Investigational Phase 4 53123-88-9 5284616 6436030 46835353
26
Misoprostol Approved Phase 4 59122-46-2 5282381
27
Levonorgestrel Approved, Investigational Phase 4 797-63-7, 17489-40-6 13109
28
Naproxen Approved, Vet_approved Phase 4 22204-53-1 1302 156391
29
Letrozole Approved, Investigational Phase 4 112809-51-5 3902
30
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
31
Mifepristone Approved, Investigational Phase 4 84371-65-3 55245
32
Progesterone Approved, Vet_approved Phase 4 57-83-0 5994
33
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
34
Pregabalin Approved, Investigational Phase 4 148553-50-8 5486971
35
Glycine Approved, Nutraceutical, Vet_approved Phase 4 56-40-6 750
36
Vitamin D3 Approved, Nutraceutical Phase 4 67-97-0 5280795 6221
37
Vitamin E Approved, Nutraceutical, Vet_approved Phase 4 59-02-9 14985
38
Niacin Approved, Investigational, Nutraceutical Phase 4 59-67-6 938
39
Cyanocobalamin Approved, Nutraceutical Phase 4 68-19-9 44176380
40
Thiamine Approved, Investigational, Nutraceutical, Vet_approved Phase 4 59-43-8, 70-16-6 1130
41
Riboflavin Approved, Investigational, Nutraceutical, Vet_approved Phase 4 83-88-5 493570
42
Vitamin C Approved, Nutraceutical Phase 4 50-81-7 5785 54670067
43
Beta carotene Approved, Nutraceutical Phase 4 7235-40-7
44
Folic acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
45
Pyridoxine Approved, Investigational, Nutraceutical, Vet_approved Phase 4 65-23-6 1054
46
Imidacloprid Vet_approved Phase 4 105827-78-9 86418
47
Cobalamin Experimental Phase 4 13408-78-1 6857388
48
Fibrinolysin Investigational Phase 4 9004-09-5
49 Ulipristal acetate Phase 4 126784-99-4
50 Contraceptive Agents Phase 4
51 Antineoplastic Agents, Hormonal Phase 4
52 Contraceptive Agents, Male Phase 4
53 Calciferol Phase 4
54 Carotenoids Phase 4
55 Nicotinic Acids Phase 4
56 Vitamin B 12 Phase 4
57 Thiamin Phase 4
58 Tocopherols Phase 4
59 Vitamin B3 Phase 4
60 Vitamin B2 Phase 4
61 Vitamin B12 Phase 4
62 Antipyretics Phase 4
63 Sodium Channel Blockers Phase 4
64 Anti-Arrhythmia Agents Phase 4
65 Diuretics, Potassium Sparing Phase 4
66 Immunologic Factors Phase 4
67 Anti-Infective Agents Phase 4
68 Immunosuppressive Agents Phase 4
69 Anti-Bacterial Agents Phase 4
70 Antifungal Agents Phase 4
71 Antibiotics, Antitubercular Phase 4
72 Vitamins Phase 4
73 Trace Elements Phase 4
74 Nutrients Phase 4
75 Micronutrients Phase 4
76 Vitamin B 6 Phase 4
77 Progestins Phase 4
78 Vitamin B Complex Phase 4
79 Folate Phase 4
80 Vitamin B9 Phase 4
81 Plasminogen Phase 4
82 Gastrointestinal Agents Phase 4
83 Antacids Phase 4
84 Anti-Ulcer Agents Phase 4
85 Vasopressins Phase 4
86 Arginine Vasopressin Phase 4
87 Hormone Antagonists Phase 4
88 Estrogen Antagonists Phase 4
89 Estrogen Receptor Antagonists Phase 4
90 Estrogens Phase 4
91 Aromatase Inhibitors Phase 4
92 Anesthetics Phase 4
93 Anesthetics, Local Phase 4
94 Hormones Phase 4
95 Contraceptives, Oral Phase 4
96 Contraceptives, Postcoital Phase 4
97 Calcium, Dietary Phase 4
98 Anticonvulsants Phase 4
99 Analgesics Phase 4
100 Analgesics, Non-Narcotic Phase 4
101 Anti-Inflammatory Agents Phase 4
102 Anti-Inflammatory Agents, Non-Steroidal Phase 4
103 Antirheumatic Agents Phase 4
104 Cyclooxygenase Inhibitors Phase 4
105 Anti-Anxiety Agents Phase 4
106 Cyclooxygenase 2 Inhibitors Phase 4
107 Psychotropic Drugs Phase 4
108 calcium channel blockers Phase 4
109
Pyridoxal Experimental, Nutraceutical Phase 4 66-72-8 1050
110
Calcium Nutraceutical Phase 4 7440-70-2 271
111
Simvastatin Approved Phase 3 79902-63-9 54454
112
acetic acid Approved Phase 3 64-19-7 176
113
Turmeric Approved, Experimental, Investigational Phase 3
114
Alprostadil Approved, Investigational Phase 2, Phase 3 745-65-3 149351 5280723
115
Epinephrine Approved, Vet_approved Phase 3 51-43-4 5816
116
Racepinephrine Approved Phase 3 329-65-7 838
117
Norethindrone Approved Phase 3 68-22-4 6230
118
Estrad